A significant reduction in the severity of endotoxemia and improvement in albumin function was observed in the DIALIVE group, which translated into a significant reduction in the CLIF-C organ failure and CLIF-C ACLF scores at Day 10 and a faster time to resolution of ACLF.77Biomarkers of systemic inflammation, cell death, endothelial function, and ligands for TLR-4 and inflammasome improved significantly in DIALIVE group. This evidence concerns the gene ALB and serum lipopolysaccharide activity.